AstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines for some of the world's most serious diseases. But we're more than one of the world's leading pharmaceutical companies. Join a dedicated Oncology team that's growing fast and building a strong track record of success. We make bold moves at the cutting edge, transforming molecules to change the practice of medicine. We have multiple indications and many high-quality molecules at all stages of development - but we see even more potential. Late Development Oncology sits within our broader Oncology Research & Development organization.Working with one of the broadest and deepest Oncology pipelines in the industry offers the possibility to work on the most novel molecules at all development stages. It takes each of us challenging our thinking to keep pushing our pipeline forward and shape the future of Oncology. Late Development Oncology develops Phase II-III trials, this role will focus on Lung Oncology studies. We are diligent and committed to our science-driven approach, with a sharp focus on outcomes. We play an important part on the Clinical Project Team (CPT) and Global Study Team (GST) working collaboratively and cross-functionally (in a matrix environment) with other CPT, GST and GPT members, Site Management & Monitoring (SMM), field-based liaisons, and site personnel. Collaborating closely with the respective Medical Scientist counterpart, our accountabilities include clinical support for the development and implementation of late phase AstraZeneca sponsored clinical program strategies, including providing input into design & implementation of clinical trial(s), their delivery, clinical data review, interpretation of results, reporting successfully on time, and activities required for worldwide registration of the product (i.e., clinical input to (s)NDA/(s)BLA.By joining our team, you will play a meaningful role in the medical monitoring, ensuring safety to patients. You will also share responsibility with Clinical Operations team members in the planning, execution and closure of a clinical study. Additionally, you may also provide expert input or lead functional process improvement initiatives and provide expert contributions to cross asset, cross tumour working groups or cross Therapy Areas, depending on the level of experience. As a key team member, this position demands strong collaborative communication skills. Someone who can engage with and influence a diverse range of partners both within and external to AstraZeneca.Responsibilities:Responsible for ensuring the risk-benefit of a clinical study, ensuring that all clinical studies operate to the highest ethical and safety standards and in compliance FDA, EMEA, ICH and GCP guidelines as well as SOPs regarding safety.Work cross functionally within clinical product teams (CPT) to ensure the clinical strategy is translated into the development of the study concept document, study protocol and related documents (such as Global ICF, CRF, TFL shells, etc).Develop relationships with appropriate consultants and key external experts (KEE), study sites, and utilize these relationships to obtain feedback on protocol design, as well as study training, study execution, and interpretation of study results, and inform recruitment strategies.Responsible for the relevance and accuracy of clinical science underpinning of clinical study based on detailed scientific review and consultation.Accountable for the clinical and scientific leadership and integrity of protocols and/or components of clinical plans (including, but not limited to, the ICF, CRF, TFL Shells, and Safety Reports).Supports or leads interactions with global medical affairs, marketing companies, commercial, and regulatory functions in collaboration with GCH/GCPL to ensure cross functional input into protocols.Contributes to technical review of protocols with governance bodies such as DRC and PRC.Contributes to the development of Medical Oversight Plan (MOP), study level safety reviews, and study-level medical monitoring activities.Core member of the GST representing Clinical Development.Responsible for the clinical input into Feasibility Questionnaires and consulted on country and site selection.Assures oversight of collected data, monitoring safety and efficacy within a study.Responsible for timely responses to investigational study sites for local ICF changes, protocol & EC/IRB questions/requests.Proactively engage with MSLs to build strong partnerships with SMMs and KEEs to provide robust feasibility assessments and streamline study execution.Contribute to development and delivery of investigator and monitor training.Contributes to the review and interpretation of clinical data (HLRs) and the development of content needed for governance.
#J-18808-Ljbffr
